⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Growth Hormone Receptor Inhibition
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-01 — Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction.: cross-connection with pdk4-inhibitors: Hepatocyte-specific GHR ablation accelerates (rather than slows) aging in mice via PPARγ–PDK4/CD36-driven mitochondrial dysfunction — a tissue-specific counterpoint to the longevity benefits seen with systemic GHR loss, and the mechanistic basis for PDK4 as a downstream rescue target. (novelty: 3)
- 2026-09-07 — Mice With Growth Hormone Halted in Middle Age Live Longer: News report on an Aging Cell mouse study: inducible knockdown of growth hormone receptor production initiated in middle age significantly extended lifespan, extending the classic lifelong GHR/IGF-1 disruption literature to a midlife-onset intervention (animal-model, reported via news). [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Mice With Growth Hormone Halted in Middle Age Live Longer
07-sep-2026
novelty 3
per-area 3
strengthens